SCHEMBL7066709

SCHEMBL7066709

CCC(C)c1cc(Br)cc(Br)c1OCCO

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
MCHR1 Q99705 1/20 0.41
GABRA1 P14867 1/20 0.37
GABRB1 P18505 1/20 0.37
THRB P10828 7/20 0.35
THRA P10827 6/20 0.35
MCL1 Q07820 1/20 0.34
ALOX15 P16050 1/20 0.33
ALOX12 P18054 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
ALDH1A1 P00352 1/20 0.32
POLB P06746 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TSHR P16473 1/20 0.32
ATM Q13315 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7067871 0.88 MEN1 (0.40) MEN1KMT2AGABRA1GABRB1THRB
SCHEMBL7067636 0.82 THRB (0.38) MEN1KMT2AGABRA1GABRB1THRB
SCHEMBL7061577 0.81 GABRA1 (0.35) KMT2AGABRA1GABRB1THRBTHRA
SCHEMBL1534879 0.81 THRA (0.35) MEN1KMT2AGABRA1GABRB1THRB
SCHEMBL4683298 0.80 THRA (0.33) MEN1KMT2AGABRA1GABRB1THRB
SCHEMBL7066275 0.80 GABRA1 (0.38) GABRA1GABRB1THRBTHRAALOX15
SCHEMBL7066995 0.79 GABRA1 (0.33) KMT2AGABRA1GABRB1ALOX15ALOX12
SCHEMBL6285005 0.78 MEN1 (0.55) MEN1KMT2AMCHR1THRBTHRA
SCHEMBL7065851 0.78 THRB (0.40) MEN1KMT2ATHRBTHRAMCL1
SCHEMBL7066987 0.78 THRB (0.38) MEN1KMT2ATHRBTHRAMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109776-B1 BROMINATED MATERIALS MINNESOTA MINING & MFG (US) 2003-06-04 EP disclosed
US-6533959-B2 Formed from monomers such as 2-(4,6-dibromo-2-isopropyl phenoxy)ethyl acrylate; high index of refraction, useful to control flow and intensity of light 3M INNOVATIVE PROPERTIES COMPANY 2003-03-18 US disclosed
US-20020123590-A1 Brominated materials 3M INNOVATIVE PROPERTIES COMPANY 2002-09-05 US disclosed
US-6359170-B1 Brominated materials 3M INNOVATIVE PROPERTIES COMPANY 2002-03-19 US disclosed
US-6261700-B1 HARD COATING 3M INNOVATIVE PROPERTIES COMPANY 2001-07-17 US disclosed
EP-1109776-A1 BROMINATED MATERIALS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 2001-06-27 EP disclosed
EP-1105430-A1 CERAMER CONTAINING A BROMINATED POLYMER AND INORGANIC OXIDE PARTICLES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 2001-06-13 EP disclosed
WO-2000014050-A1 BROMINATED MATERIALS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 2000-03-16 WO disclosed
WO-2000006622-A1 CERAMER CONTAINING A BROMINATED POLYMER AND INORGANIC OXIDE PARTICLES MINNESOTA MINING AND MANUFACTURING COMPANY (US) 2000-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020123590-A1 Brominated materials PBRM1, TUBB3, TUBB MEN1 2240/4885KMT2A 1043/4885MCHR1 2936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.